Wednesday, at the age of 69, Al Biernat died following a seven-month battle with ALS and those who worked closest to him will ...

Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...

A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...

Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...

Restaurateur Al Biernat passed away on Wednesday, November 13, after being diagnosed with amyotrophic lateral sclerosis, also ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Amyotrophic Lateral Sclerosis Disease Program (PMN267) PMN267 is a humanized IgG1 antibody directed against toxic misfolded TDP-43 as a potential therapeutic target for amyotrophic lateral sclerosis ...

ALS is a neurodegenerative disease that progressively paralyzes individuals as the brain loses the ability to communicate with the muscles. People living with ALS often experience a swift decline in ...

The Oak Ridge Boys are on their “American Made” farewell tour and the group seems sincere about saying goodbye to the ...

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.

We are particularly interested in studies that integrate engineering breakthroughs with clinical practice to address complex neurological conditions such as: · Alzheimer’s Disease · Amyotrophic ...

Dallas steakhouse owner Al Biernat, whose charismatic presence at his namesake restaurant attracted both the famous and the ...